COMP <GO>
XTNT vs UNH // OPERATING MARGIN
Xtant Medical Holdings Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: XTNT 6
— UNH 6
▲ OPERATING MARGIN LEADER: XTNT
LAST: $0.29 (+1.54%) • MKT CAP: $40.7M
operating-margins
5.40%
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
operating-margins
4.82%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XTNT VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XTNT | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.90% | 88.57% | -25.67 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.80% | 11.47% | +1.33 | XTNT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 3.7x | 16.4x | -12.75 | XTNT | /valuation <GO> |
| Free Cash Flow Yield | 24.95% | 6.48% | +18.47 | XTNT | /fcf-yield <GO> |
| Operating Margin ACTIVE | 5.40% | 4.82% | +0.58 | XTNT | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 3.14% | -3.14 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 14.20% | 6.46% | +7.74 | XTNT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 3.12 | -2.92 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | XTNT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.9 | 59.2 | -24.26 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $40.7M | $368.83B | -$368.79B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XTNT REV | UNH REV | XTNT GROSS % | UNH GROSS % | XTNT FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $133.9M | $447.57B | 62.9% | 88.7% | $10.2M | $16.07B |
| FY 2024 | $117.3M | $400.28B | 58.2% | 88.3% | -$16.0M | $20.70B |
| FY 2023 | $91.3M | $371.62B | — | 89.6% | -$9.5M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XTNT // BETA —
UNH // BETA 0.33